DTN statement regarding the use of Medtrum HCL systems
The DTN committee are aware that questions have arisen since the inclusion of the Medtrum HCL system in the framework, provided by NHS Supply Chain, for the procurement of HCL systems to support the implementation of NICE TA 943. The committee has 4 key concerns regarding provision of the Medtrum hybrid closed loop system to people with type 1 diabetes in the UK: